Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019
…, Y Fu, S Ge, L Liu, J Zhang, N Xia… - Clinical infectious …, 2020 - academic.oup.com
Background The novel coronavirus SARS-CoV-2 is a newly emerging virus. The antibody
response in infected patients remains largely unknown, and the clinical value of antibody …
response in infected patients remains largely unknown, and the clinical value of antibody …
Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus
…, AQ Bakker, H Spits, T Beaumont, Z Zheng, N Xia… - science, 2013 - science.org
Respiratory syncytial virus (RSV) is the leading cause of hospitalization for children under 5
years of age. We sought to engineer a viral antigen that provides greater protection than …
years of age. We sought to engineer a viral antigen that provides greater protection than …
[HTML][HTML] Methods favoring homology-directed repair choice in response to CRISPR/Cas9 induced-double strand breaks
…, S Ren, S Yu, H Pan, T Li, S Ge, J Zhang, N Xia - International journal of …, 2020 - mdpi.com
Precise gene editing is—or will soon be—in clinical use for several diseases, and more
applications are under development. The programmable nuclease Cas9, directed by a single-…
applications are under development. The programmable nuclease Cas9, directed by a single-…
[HTML][HTML] A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice
Dear Editor, Since the beginning of this century, humanity has been struck three times by the
coronavirus outbreak. The most recent one is caused by the SARS-CoV-2 virus, which was …
coronavirus outbreak. The most recent one is caused by the SARS-CoV-2 virus, which was …
Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody
The prefusion state of respiratory syncytial virus (RSV) fusion (F) glycoprotein is the target of
most RSV-neutralizing activity in human sera, but its metastability has hindered …
most RSV-neutralizing activity in human sera, but its metastability has hindered …
[HTML][HTML] A nanovaccine for antigen self-presentation and immunosuppression reversal as a personalized cancer immunotherapy strategy
…, L Zhang, X Liu, P Lv, X Wang, W Luo, N Xia… - Nature …, 2022 - nature.com
The strategy of combining a vaccine with immune checkpoint inhibitors has been widely
investigated in cancer management, but the complete response rate for this strategy is still …
investigated in cancer management, but the complete response rate for this strategy is still …
A recombinant spike protein subunit vaccine confers protective immunity against SARS-CoV-2 infection and transmission in hamsters
…, H Zhu, Q Zhao, Q Yuan, Y Guan, N Xia - Science translational …, 2021 - science.org
Multiple safe and effective vaccines that elicit immune responses against severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) are necessary to respond to the ongoing …
respiratory syndrome coronavirus 2 (SARS-CoV-2) are necessary to respond to the ongoing …
Virus-like particle-based human vaccines: quality assessment based on structural and functional properties
Q Zhao, S Li, H Yu, N Xia, Y Modis - Trends in biotechnology, 2013 - cell.com
Human vaccines against three viruses use recombinant virus-like particles (VLPs) as the
antigen: hepatitis B virus, human papillomavirus, and hepatitis E virus. VLPs are excellent …
antigen: hepatitis B virus, human papillomavirus, and hepatitis E virus. VLPs are excellent …
[HTML][HTML] Recent progress on the versatility of virus-like particles
…, J Chen, T Li, Q Zheng, H Yu, Y Gu, S Li, N Xia - Vaccines, 2020 - mdpi.com
Virus-like particles (VLPs) are multimeric nanostructures composed of one or more structural
proteins of a virus in the absence of genetic material. Having similar morphology to natural …
proteins of a virus in the absence of genetic material. Having similar morphology to natural …
[HTML][HTML] Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound
…, J Jia, J Hou, MA McCrae, Z Gao, H Ren, N Xia… - Journal of …, 2016 - Elsevier
Background & Aims Hepatitis B virus (HBV) RNA in serum has recently been linked to
efficacy and prognosis of chronic hepatitis B (CHB) treatment. This study explored the nature, …
efficacy and prognosis of chronic hepatitis B (CHB) treatment. This study explored the nature, …